Calidi Biotherapeutics appoints Dr. George Peoples to board effective July 1, 2024

Calidi Biotherapeutics, Inc.

Appointed Dr. George Peoples as director effective July 1, 2024; term expires at 2025 annual meeting.
Dr. Peoples will serve on the Compensation Committee upon appointment.
Background: 30-year military surgeon, research scientist, Founder/CEO of Cancer Insight.
Compensation per nonemployee director policy; standard indemnification agreement to be entered.
No arrangements or family relationships with directors/officers disclosed.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

George Peoples

director

CLDI · Calidi Biotherapeutics, Inc.

Effective: 2024-07-01
Filed: June 26, 2024, 7:59 PM ET

On June 20, 2024, the Board of Directors (the “Board) of Calidi Biotherapeutics, Inc. (the “Company”) appointed Dr. George Peoples as a director, effective July 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

George Peoples was appointed as director at Calidi Biotherapeutics, Inc..

Action: appointed
Role: director

Exact text from the filing

On June 20, 2024, the Board of Directors (the “Board) of Calidi Biotherapeutics, Inc. (the “Company”) appointed Dr. George Peoples as a director, effective July 1, 2024.

View on SEC.gov

Calidi Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-025267

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.